Use of high-dose ibuprofen in a pediatric cystic fibrosis center

Journal of Cystic Fibrosis

Volumn 6, Issue 2, 2007, Pages 153-158

  Fennell, Preston Blain ^a   Quante, Jane ^a   Wilson, Karen ^a   Boyle, Mary ^a   Strunk, Robert ^a   Ferkol, Thomas ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Corticosteroids; Cystic fibrosis; Ibuprofen; Inflammation

Indexed keywords

ANTIINFLAMMATORY AGENT; CORTICOSTEROID; DORNASE ALFA; HISTAMINE H2 RECEPTOR ANTAGONIST; IBUPROFEN; PANCREAS ENZYME; PROTON PUMP INHIBITOR; TOBRAMYCIN;

ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; ADJUVANT THERAPY; ADOLESCENT; ADULT; AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CHILD; CHILDHOOD DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYSTIC FIBROSIS; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG MEGADOSE; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HEMATURIA; HEMOGLOBIN BLOOD LEVEL; HEMOPTYSIS; HOSPITALIZATION; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PANCREAS INSUFFICIENCY; PATIENT COMPLIANCE; RETROSPECTIVE STUDY; SIDE EFFECT;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMANS; IBUPROFEN; LENGTH OF STAY; LUNG DISEASES; MALE; PATIENT COMPLIANCE; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33847721926     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2006.06.003     Document Type: Article

References (16)

1. FitzSimmons S.C. The changing epidemiology of cystic fibrosis. J Pediatr 122 (1993) 1-9
2. Konstan M.W., and Berger M. Current understanding of the inflammatory process in cystic fibrosis: onset and etiology. Pediatr Pulmonol 24 (1997) 137-142
3. Rosenfeld M., Gibson R.L., McNamara S., Emerson J., Burns J.L., Castile R., et al. Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol 32 (2001) 356-366
4. Nixon G.M., Armstrong D.S., Carzino R., Carlin J.B., Olinsky A., Robertson C.F., et al. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr 138 (2001) 699-704
5. Khan T.Z., Wagener J.S., Bost T., Martinez J., Accurso F.J., and Riches D.W.H. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 151 (1995) 1075-1082
6. Konstan M.W., Hilliard K.A., Norvell T.M., and Berger M. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med 150 (1994) 448-454
7. Bonfield T.L., Panuska J.R., Konstan M.W., Hilliard K.A., Hilliard J.B., Ghnaim H., et al. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 152 (1995) 2111-2118
8. Auerbach H.S., Williams M., Kirkpatrick J.A., and Colten H.R. Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis. Lancet 2 (1985) 686-688
9. Eigen H., Rosenstein B.J., FitzSimmons S., and Schidlow D.W. A multicenter study of alternate-day prednisone in patients with cystic fibrosis: Cystic Fibrosis Foundation Prednisone Trial Group. J Pediatr 126 (1995) 515-523
10. Konstan M.W., Byard P., Hoppel J.C., and Davis P.B. Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med 332 (1995) 848-854
11. 1 among young patients with mild lung disease in the CFF Registry. Pediatr Pulmonol 27 (2004) 322 [suppl, Abstract]
12. Oermann C.M., Sockrider M.M., and Konstan M.W. The use of anti-inflammatory medications in cystic fibrosis: trends and physician attitudes. Chest 115 (1999) 1053-1058
13. Cystic Fibrosis Foundation Patient Registry. 2003 Annual Data Report. 2004. Bethesda, MD.
14. Konstan M.W., Hoppel C.L., Chai B.L., and Davis P.B. Ibuprofen in children with cystic fibrosis: pharmacokinetics and adverse effects. J Pediatr 118 (1991) 956-964
15. Rosenbluth D.B., Wilson K., Ferkol T., and Schuster D.P. Lung function decline in cystic fibrosis patients and timing for lung transplantation referral. Chest 126 (2004) 412-419
16. Mackey J.E., and Anbar R.D. High-dose ibuprofen therapy associated with esophageal ulceration after pneumonectomy in a patient with cystic fibrosis: a case report. BMC Pediatr 4 (2004) 19